A feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma in Australia
العنوان: | A feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma in Australia |
---|---|
المؤلفون: | Emma Priest, Christopher Thien, Michael Murphy, Santosh Kesari, Anthony Dowling, Donna Morgan Murray |
المصدر: | CNS Oncology |
بيانات النشر: | Future Medicine Ltd, 2019. |
سنة النشر: | 2019 |
مصطلحات موضوعية: | electromagnetic fields, medicine.medical_specialty, Medical device, recurrent GBM, Treatment outcome, Clinical Trial Evaluation, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Radio frequency energy, Overall survival, Humans, Medicine, In patient, Adverse effect, brain cancer, medical device, Brain Neoplasms, business.industry, Recurrent glioblastoma, glioblastoma, clinical trial, General Medicine, Clinical trial, 030220 oncology & carcinogenesis, Nativis Voyager, Feasibility Studies, Radiology, business, 030217 neurology & neurosurgery |
الوصف: | Aim: Evaluation of the Nativis Voyager®, an investigational medical device, as monotherapy for recurrent glioblastoma (rGBM). Materials & methods: A total of 15 patients with rGBM were treated with one of two Voyager ultra-low radio frequency energy cognates: A1A or A2HU. Safety and clinical utility were assessed every 2–4 months. Results: Median overall survival was 8.04 months in the A1A arm and 6.89 months in the A2HU arm. No serious adverse events associated with Voyager were reported. No clinically relevant trends were noted in clinical laboratory parameters or physical exams. Conclusion: The data suggest that the Voyager is safe and feasible for the treatment of rGBM. |
تدمد: | 2045-0915 2045-0907 |
الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37cafe68747e2ffeb44c92c478687cd6Test https://doi.org/10.2217/cns-2018-0017Test |
حقوق: | OPEN |
رقم الانضمام: | edsair.doi.dedup.....37cafe68747e2ffeb44c92c478687cd6 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 20450915 20450907 |
---|